HIV–HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance
P. Schirmer, M. Winters, M. HolodniyVolume:
52
Year:
2011
Language:
english
DOI:
10.1016/j.jcv.2011.07.014
File:
PDF, 166 KB
english, 2011